Sooma Oy

Helsinki, Finland Founded: 2013 • Age: 13 yrs
Non-invasive neuromodulation therapies
Annual revenue - Latest available
Total funding $6.6M 6 rounds
Employees - Tracked headcount
Investors 7 Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About Sooma Oy

Sooma Oy is a company based in Helsinki (Finland) founded in 2013. Sooma Oy has raised $6.58 million across 6 funding rounds from investors including European Union, Business Finland and Voima Ventures. Sooma Oy offers products and services including Sooma tDCS. Sooma Oy operates in a competitive market with competitors including Theranica, Freespira, Bone Health Technologies, Mainstay Medical and Cervel, among others.

  • Headquarter Helsinki, Finland
  • Sectors
    Technology
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sooma Oy
Operational Areas
Technology → Extended, Virtual & Augmented Reality
Healthcare → Healthcare Products & Supplies
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.58 M (USD)

    in 6 rounds

  • Latest Funding Round
    $5.47 M (USD), Series B

    Mar 13, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sooma Oy

Sooma Oy offers a comprehensive portfolio of products and services, including Sooma tDCS.

Primary

Noninvasive device for treating depression and chronic pain via electrical stimulation.

People of Sooma Oy

Headcount 1-10
Employee Profiles 8
Employee Profiles
People
Tuomas Neuvonen
CEO and Founder
People
Fares Gharbi
Key Account Manager
People
Mika Nikander
Chief Operating Officer
People
Ville Andsten
Business Development Manager

Unlock access to complete

Funding Insights of Sooma Oy

Sooma Oy has successfully raised a total of $6.58M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $5.47 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series B — $5.5M
  • First Round
  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2024 Amount Series B - Sooma Oy Valuation Voima Ventures
Jun, 2022 Amount Grant - Sooma Oy Valuation

investors

Jul, 2020 Amount Grant - Sooma Oy Valuation

investors

Investors in Sooma Oy

Sooma Oy has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Business Finland and Voima Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Funding is provided for deep tech ventures in Nordics.
Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Venture capital investment in early-stage technology, life science, and Health startups
Founded Year Domain Location

Investments & Acquisitions by Sooma Oy

Investments

Financial Statements - Sooma Oy

Sooma Oy Comparisons

+
Add Comparison
Available on Premium

Competitors of Sooma Oy

Sooma Oy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theranica, Freespira, Bone Health Technologies, Mainstay Medical and Cervel, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic devices for pain management are developed and manufactured.
domain founded_year HQ Location
Panic disorders are treated via breathing device and mobile app.
domain founded_year HQ Location
Bone Health Technologies creates a wearable device to treat osteopenia and prevent osteoporosis.
domain founded_year HQ Location
Provider of rehabilitation solutions for patients and doctors
domain founded_year HQ Location
Treatment-resistant depression is addressed through non-invasive transcranial magnetic stimulation.

Latest news on Sooma Oy

Frequently Asked Questions about Sooma Oy

Sooma Oy was founded in 2013 and raised its 1st funding round 4 years after it was founded.

Sooma Oy is headquartered in Helsinki, Finland.

Sooma Oy is a funded company, having raised a total of $6.58M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.81M, raised on May 13, 2017.

Sooma Oy is developing a non-invasive brain stimulation device, a treatment option for major neurological and psychiatric disorders. Initial product tDCS targets major depressive disorder and is CE Marked.

Sooma Oy's top competitors include Theranica, Mainstay Medical and ZetrOZ.

Sooma Oy offers Sooma tDCS.

Sooma Oy has 7 investors. Key investors include European Union, Business Finland, Voima Ventures, Verge HealthTech Fund, and Stephen Industries.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available